» Articles » PMID: 31890836

Pediatric Diabetes in Saudi Arabia: Challenges and Potential Solutions. A Review Article

Overview
Date 2020 Jan 1
PMID 31890836
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes in children has increased globally, and the World Health Organization ranks Saudi Arabia 7th in prevalence and 5th in incidence of type 1 diabetes (T1D). Type 2 diabetes (T2D) in children and adolescents has been identified in Saudi Arabia but its prevalence is still unknown. Despite advances in diabetes management including new insulins, insulin delivery systems, glucose monitoring and easy access to media for disease awareness, diabetes in children continues to be challenging in many aspects. Problems include delayed diagnosis, suboptimal glycemic control, early and late disease complications, transition from pediatric to adult care and raising of obesity and T2D, poor psychological and school support. This review summarizes the pediatric and adolescent diabetes studies in Saudi Arabia to date and explores the country-specific treatment challenges and potential solutions.

Citing Articles

Association of vitamin D deficiency and insufficiency with uncontrolled type 1 diabetes Mellitus among Saudi pediatric patients; a hospital-based retrospective study.

Almansour S, Alsalamah A, Almutlaq M, Sheikh A, Hamdan H, Al-Nafeesah A Front Pediatr. 2025; 12():1479815.

PMID: 39845452 PMC: 11753226. DOI: 10.3389/fped.2024.1479815.


The increase in diabetes in children from underdeveloped countries.

Zhang C, Luo X Curr Opin Pediatr. 2024; 36(4):467-472.

PMID: 38832684 PMC: 11224563. DOI: 10.1097/MOP.0000000000001366.


Information needs on type 1 diabetes mellitus (T1DM) and its management in children and adolescents: a qualitative study.

Muhammed Elamin S, Muhamad Arshad N, Md Redzuan A, Abdul Aziz S, Hong J, Chua X BMJ Open. 2024; 14(4):e079606.

PMID: 38569693 PMC: 10989179. DOI: 10.1136/bmjopen-2023-079606.


Correlation analysis between cytokines' profile, autoimmune antibodies and the duration of type 1 diabetes: A case control study in a specialized children's centre in Riyadh.

Al-Dubayee M, Babiker A, Alkewaibeen A, Alkhalifah A, Alanazi T, Nogoud M Int J Immunopathol Pharmacol. 2023; 37:3946320231209821.

PMID: 37953627 PMC: 10644762. DOI: 10.1177/03946320231209821.


Determinants of health-related quality of life in children and adolescents living with type 1 diabetes mellitus during the COVID-19 pandemic.

Smudja M, Milenkovic T, Minakovic I, Zdravkovic V, Mitic S, Milutinovic D Nurs Open. 2023; 10(11):7394-7410.

PMID: 37688291 PMC: 10563408. DOI: 10.1002/nop2.1993.


References
1.
. Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care. 1995; 18(11):1415-27. DOI: 10.2337/diacare.18.11.1415. View

2.
Ahmed A, Al-Maghamsi M, Al-Harbi A, Eid I, Baghdadi H, Habeb A . Reduced frequency and severity of ketoacidosis at diagnosis of childhood type 1 diabetes in Northwest Saudi Arabia. J Pediatr Endocrinol Metab. 2015; 29(3):259-64. DOI: 10.1515/jpem-2015-0077. View

3.
Salman H, Abanamy A, Ghassan B, Khalil M . Childhood diabetes in Saudi Arabia. Diabet Med. 1991; 8(2):176-8. DOI: 10.1111/j.1464-5491.1991.tb01567.x. View

4.
Hekkala A, Knip M, Veijola R . Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years. Diabetes Care. 2007; 30(4):861-6. DOI: 10.2337/dc06-2281. View

5.
Robert A, Al-Dawish A, Mujammami M, Al Dawish M . Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic. Int J Pediatr. 2018; 2018:9408370. PMC: 5964576. DOI: 10.1155/2018/9408370. View